skip to main content

H.R. 5021: Stop Online Opioid Sales Act of 2018

To require the Administrator of the Drug Enforcement Administration to make publicly available on the website of the Drug Enforcement Administration a report on the sale of controlled substances and controlled substance analogues by means of the Internet.

The bill’s titles are written by its sponsor.

Sponsor and status

Sean Maloney

Sponsor. Representative for New York's 18th congressional district. Democrat.

Read Text »
Last Updated: Feb 14, 2018
Length: 3 pages

Feb 14, 2018


Introduced on Feb 14, 2018

This bill is in the first stage of the legislative process. It was introduced into Congress on February 14, 2018. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.


2% chance of being enacted according to Skopos Labs (details)


Feb 14, 2018

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Ordered Reported

Passed House (Senate next)

Passed Senate

Signed by the President

H.R. 5021 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5021 — 115th Congress: Stop Online Opioid Sales Act of 2018.” 2018. March 22, 2018 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.